Convatec Group (CTEC) Competitors

Convatec Group logo
GBX 250.20 -2.60 (-1.03%)
As of 05:59 AM Eastern

CTEC vs. SN, AMS, NIOX, TSTL, and EKF

Should you buy Convatec Group stock or one of its competitors? Convatec Group's main competitors and comparable companies include Smith & Nephew (SN), Advanced Medical Solutions Group (AMS), NIOX Group (NIOX), Tristel (TSTL), and EKF Diagnostics (EKF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Convatec Group compare to Smith & Nephew?

Convatec Group (LON:CTEC) and Smith & Nephew (LON:SN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

In the previous week, Convatec Group had 1 more articles in the media than Smith & Nephew. MarketBeat recorded 2 mentions for Convatec Group and 1 mentions for Smith & Nephew. Convatec Group's average media sentiment score of 0.00 equaled Smith & Nephew'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Convatec Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Smith & Nephew
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smith & Nephew has higher revenue and earnings than Convatec Group. Convatec Group is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Convatec Group£2.49B1.92£188.35M£6.2040.35
Smith & Nephew£7.08B1.82£382.79M£27.7742.34

Convatec Group has a beta of 0.765, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Smith & Nephew has a beta of 0.688, indicating that its stock price is 31% less volatile than the broader market.

Convatec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 2.9%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.5%. Convatec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

70.1% of Convatec Group shares are owned by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are owned by institutional investors. 1.0% of Convatec Group shares are owned by insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Smith & Nephew has a net margin of 10.08% compared to Convatec Group's net margin of 4.99%. Smith & Nephew's return on equity of 12.25% beat Convatec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Convatec Group4.99% 8.40% 5.01%
Smith & Nephew 10.08%12.25%4.51%

Convatec Group currently has a consensus target price of GBX 305.44, indicating a potential upside of 22.08%. Smith & Nephew has a consensus target price of GBX 1,242.50, indicating a potential upside of 5.65%. Given Convatec Group's stronger consensus rating and higher probable upside, equities analysts plainly believe Convatec Group is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Convatec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Smith & Nephew
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Convatec Group beats Smith & Nephew on 10 of the 17 factors compared between the two stocks.

How does Convatec Group compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and Convatec Group (LON:CTEC) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Advanced Medical Solutions Group pays an annual dividend of GBX 2.86 per share and has a dividend yield of 1.0%. Convatec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 2.9%. Advanced Medical Solutions Group pays out 173.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Convatec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Convatec Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Advanced Medical Solutions Group currently has a consensus target price of GBX 278.33, suggesting a potential downside of 1.50%. Convatec Group has a consensus target price of GBX 305.44, suggesting a potential upside of 22.08%. Given Convatec Group's stronger consensus rating and higher probable upside, analysts clearly believe Convatec Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Convatec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Convatec Group has higher revenue and earnings than Advanced Medical Solutions Group. Convatec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£233.63M2.63£11.22M£1.65171.25
Convatec Group£2.49B1.92£188.35M£6.2040.35

Convatec Group has a net margin of 4.99% compared to Advanced Medical Solutions Group's net margin of 1.58%. Convatec Group's return on equity of 8.40% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group1.58% 1.44% 2.35%
Convatec Group 4.99%8.40%5.01%

Advanced Medical Solutions Group has a beta of 0.759, indicating that its share price is 24% less volatile than the broader market. Comparatively, Convatec Group has a beta of 0.765, indicating that its share price is 24% less volatile than the broader market.

21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 70.1% of Convatec Group shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 1.0% of Convatec Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Convatec Group had 2 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for Convatec Group and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.80 beat Convatec Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
Convatec Group Neutral

Summary

Convatec Group beats Advanced Medical Solutions Group on 14 of the 18 factors compared between the two stocks.

How does Convatec Group compare to NIOX Group?

Convatec Group (LON:CTEC) and NIOX Group (LON:NIOX) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

70.1% of Convatec Group shares are owned by institutional investors. Comparatively, 7.6% of NIOX Group shares are owned by institutional investors. 1.0% of Convatec Group shares are owned by company insiders. Comparatively, 5.1% of NIOX Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Convatec Group currently has a consensus target price of GBX 305.44, indicating a potential upside of 22.08%. NIOX Group has a consensus target price of GBX 86, indicating a potential upside of 36.51%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts plainly believe NIOX Group is more favorable than Convatec Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Convatec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
NIOX Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NIOX Group has lower revenue, but higher earnings than Convatec Group. NIOX Group is trading at a lower price-to-earnings ratio than Convatec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Convatec Group£2.49B1.92£188.35M£6.2040.35
NIOX Group£47.50M5.37£995.88M£1.6338.65

Convatec Group has a beta of 0.765, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

NIOX Group has a net margin of 14.74% compared to Convatec Group's net margin of 4.99%. NIOX Group's return on equity of 10.01% beat Convatec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Convatec Group4.99% 8.40% 5.01%
NIOX Group 14.74%10.01%3.95%

Convatec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 2.9%. NIOX Group pays an annual dividend of GBX 1.55 per share and has a dividend yield of 2.5%. Convatec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Convatec Group and Convatec Group both had 2 articles in the media. NIOX Group's average media sentiment score of 0.76 beat Convatec Group's score of 0.00 indicating that NIOX Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Convatec Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NIOX Group
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

NIOX Group beats Convatec Group on 10 of the 17 factors compared between the two stocks.

How does Convatec Group compare to Tristel?

Tristel (LON:TSTL) and Convatec Group (LON:CTEC) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

22.4% of Tristel shares are held by institutional investors. Comparatively, 70.1% of Convatec Group shares are held by institutional investors. 21.0% of Tristel shares are held by company insiders. Comparatively, 1.0% of Convatec Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Convatec Group has a consensus price target of GBX 305.44, indicating a potential upside of 22.08%. Given Convatec Group's stronger consensus rating and higher probable upside, analysts clearly believe Convatec Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Convatec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Convatec Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Convatec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£51.12M3.64£6.54M£16.5723.39
Convatec Group£2.49B1.92£188.35M£6.2040.35

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.7%. Convatec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 2.9%. Tristel pays out 85.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Convatec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel is clearly the better dividend stock, given its higher yield and lower payout ratio.

Tristel has a net margin of 15.62% compared to Convatec Group's net margin of 4.99%. Tristel's return on equity of 23.05% beat Convatec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.62% 23.05% 9.89%
Convatec Group 4.99%8.40%5.01%

In the previous week, Convatec Group had 2 more articles in the media than Tristel. MarketBeat recorded 2 mentions for Convatec Group and 0 mentions for Tristel. Tristel's average media sentiment score of 0.00 equaled Convatec Group'saverage media sentiment score.

Company Overall Sentiment
Tristel Neutral
Convatec Group Neutral

Tristel has a beta of 0.352, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Convatec Group has a beta of 0.765, meaning that its stock price is 24% less volatile than the broader market.

Summary

Convatec Group beats Tristel on 9 of the 17 factors compared between the two stocks.

How does Convatec Group compare to EKF Diagnostics?

Convatec Group (LON:CTEC) and EKF Diagnostics (LON:EKF) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

Convatec Group presently has a consensus target price of GBX 305.44, suggesting a potential upside of 22.08%. EKF Diagnostics has a consensus target price of GBX 35, suggesting a potential upside of 46.44%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe EKF Diagnostics is more favorable than Convatec Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Convatec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Convatec Group has higher revenue and earnings than EKF Diagnostics. Convatec Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Convatec Group£2.49B1.92£188.35M£6.2040.35
EKF Diagnostics£51.35M1.99£4.68M£0.5841.21

70.1% of Convatec Group shares are owned by institutional investors. Comparatively, 21.5% of EKF Diagnostics shares are owned by institutional investors. 1.0% of Convatec Group shares are owned by company insiders. Comparatively, 40.2% of EKF Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Convatec Group had 1 more articles in the media than EKF Diagnostics. MarketBeat recorded 2 mentions for Convatec Group and 1 mentions for EKF Diagnostics. Convatec Group's average media sentiment score of 0.00 equaled EKF Diagnostics'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Convatec Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
EKF Diagnostics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Convatec Group has a net margin of 4.99% compared to EKF Diagnostics' net margin of 4.86%. Convatec Group's return on equity of 8.40% beat EKF Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Convatec Group4.99% 8.40% 5.01%
EKF Diagnostics 4.86%3.58%5.27%

Convatec Group has a beta of 0.765, suggesting that its share price is 24% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.503, suggesting that its share price is 50% less volatile than the broader market.

Summary

Convatec Group beats EKF Diagnostics on 9 of the 15 factors compared between the two stocks.

Get Convatec Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTEC vs. The Competition

MetricConvatec GroupHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£4.78B£5.96B£7.83B£2.81B
Dividend Yield2.15%1.69%2.46%5.11%
P/E Ratio40.3536.9933.7323.22
Price / Sales1.925.428.565.16
Price / Cash17.0123.9521.9320.23
Price / Book3.134.374.322.42
Net Income£188.35M£143.12M£3.52B£5.88B
7 Day Performance0.16%-3.77%-4.45%-0.97%
1 Month Performance4.95%-2.80%-3.51%-2.67%
1 Year Performance4.60%0.23%0.14%6.74%

Convatec Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTEC
Convatec Group
2.6037 of 5 stars
GBX 250.20
-1.0%
GBX 305.44
+22.1%
+4.2%£4.78B£2.49B40.3510,000
SN
Smith & Nephew
1.2956 of 5 stars
GBX 1,138.50
-0.2%
GBX 1,242.50
+9.1%
-5.8%£12.48B£7.08B40.9918,452
AMS
Advanced Medical Solutions Group
0.2935 of 5 stars
GBX 283
flat
GBX 278.33
-1.6%
+33.2%£616.37M£233.63M171.5210
NIOX
NIOX Group
2.2209 of 5 stars
GBX 63.60
-1.2%
GBX 86
+35.2%
-10.7%£257.73M£47.50M39.0292
TSTL
Tristel
N/AGBX 391.70
-0.8%
N/A+5.3%£188.30M£51.12M23.64208

Related Companies and Tools


This page (LON:CTEC) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners